A new approach that used CRISPR to engineer adipocytes and implant them in mice models of cancer reduced cancer progression.

A new drug delivery system shows promise for treating a rare, aggressive form of cancer affecting pregnant women and new ...

CAMBRIDGE, Mass. - Immuneering Corporation (NASDAQ:IMRX), a clinical-stage oncology company with a market capitalization of $59.31 million, has entered into a clinical supply agreement with Regeneron ...

New England Journal of Medicine Publishes eNRGy Trial Evaluating Zenocutuzumab-zbco (BIZENGRI®) in NRG1+ cancer ...